Abstract:
A descriptive cross-sectional study to determine the pattern of in-patient morbidity of noncommunicable diseases and demographic and socio-economic characteristics of the patients
and to estimate the economic burden of these diseases on the households and the health
system. When medical costs of treating selected were considered, cost of investigations
made the largest contribution to the treatment costs of ischemic heart disease .Stroke and
asthma .Cost of medication accounted for the largest proportion of the treatment costs of
myocardial infarction and cirrhosis. a significant difference in treatment costs between the
four units was observed only for ischemic heart disease.
